PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
This will be a TBD in FY2011 because the centrally managed CoAg with the World Health Organization (WHO) for the blood safety TA to Ministry of Health Blood Safety program has expired on March 31, 2010. The HQ Blood Safety Team is developing a Task Order Contract mechanism to provide Technical Assistance to recipient countries which will be awarded in FY2011 and is designed to support short-term technical assistance and to fund a comprehensive package of blood safety technical assistance.
Since 2004, the National Blood Transfusion Services (NBTS) of the Federal Ministry of Health (FMoH) Ethiopia has received funding from PEPFAR as a construction and non-construction grant to strengthen the blood transfusion services in Ethiopia in order to ensure the safety and adequacy of the national blood supply. During this period (with technical assistance from the World Health Organization), the core achievements of the NBTS included: development of a national blood policy and a five-year strategic plan for the years 20062010; testing 100% of donated blood units for transfusion-transmitted infections (including HIV); training prescribers and users of blood products in order to improve the therapeutic and clinical use of blood; and development of national guidelines, protocols, standards, and standard operating procedures (SOPs) to ensure the delivery of high-quality blood services.
In Ethiopia as in many developing countries, substantial problems have been noted in the following blood safety areas: (1) Assessment of demand for blood and determination of adequacy of the blood supply (assuring that a sufficient amount of safe blood is collected to meet the country's annual demand); (2) Reliance on family identified replacement donors instead of voluntary, non-remunerated donors with a low behavioral risk profile for HIV; (3) Laboratory capacity both at processing and distribution sites; (4) Monitoring and evaluation to assure quality systems from vein to vein ( e.g. maintenance of cold chain, data management); (5) Commodities forecasting, procurement and distribution to avoid stock outs; (6) Management, training and supervision; and (7) Adverse event monitoring.
Blood transfusion services in Ethiopia are at a turning point since the Ministry of Health has decided to revert the services from the Ethiopian Red Cross Society (ERCS) to FMoH and Regional Health Bureaus (RHBs) with the main purpose of integrating and coordinating the blood safety services within the health system. This in effect involves establishing the NBTS under FMoH and RHBs almost from scratch. Therefore, there is going to be an unprecedented increase in the requirement for TA in FY2011 especially as blood transfusion services are being newly established and are a relatively new venture both at for the FMoH and RHBs. In FY2011, a task order contract with a TBD partner will support the PEPFAR-funded blood safety initiative in Ethiopia for establishing a strong blood safety program in the Ethiopian MOH/NBTS.
The new task order contract will support the PEPFAR-funded blood safety initiative in Ethiopia by supporting the NBTS of the FMOH Ethiopia in developing strong blood safety program through the provision of technical assistance. Services funded through this contract will include, but not be limited to, providing expert advice, training and mentoring in the areas of policy revision, blood bank and laboratory infrastructure, blood collection, laboratory screening, clinical prescription strategies (i.e., appropriate clinical use of blood), transfusion procedures and practices, advice on monitoring and evaluation, and quality assurance. Additional activities may include commodity management, waste management, and overall program management for blood services.
Funding for this Task Order Contract will be from the HQ funding available for technical assistance supplemented with the PEPFAR Ethiopia COP 11 funding.
In FY2011, the TBD TA providing partner will provide technical assistance to expand and consolidate the blood safety program. This will be achieved through the six key technical areas: 1. Training: assist the development and implementation of a training plan for in-service, continuing education, and/or short and long term career development; support formal familiarization of the program for new blood bank staff; assist in the training of clinicians on appropriate clinical use of blood and blood products; assist in training of BTS staff in quality and quality systems.
2. Infrastructure Development: support situational assessment of existing infrastructure and needs for NBTS; support analysis of blood demand, blood collection, screening, processing and blood banking facilities; support reliable supplies of capital and consumable needs; support IT systems necessary to track data on blood donors, blood collections, issue and testing, and laboratory results; support establishment of a system for waste disinfection and safe disposal.
3. Blood Collection: support the development of generic and site-specific protocols for collecting, handling and storing, transporting, and distributing blood in and from fixed and mobile collection facilities; support the development of national criteria to assess the suitability of blood donors; provide advice in developing and maintaining a system to recruit and retain low risk blood donors; provide guidance on effective quality assurance and SOPs for collecting and storing blood.
4. Blood Testing and Production of Blood Products: support efforts to ensure the overall safety of the transfusion process; support the development of generic national and site-specific protocols for all required testing of blood following Good Laboratory Practice; support the strengthening blood services' capacity to manage blood testing laboratories and build capacity to fractionate blood products from collected units of whole blood.
5. Transfusion and Blood Utilization: support the revision and implementation of national guidelines for the appropriate use of blood and blood products, and compatibility testing; provide guidance and advice for the development and strengthening of hospital-based transfusion committees to monitor the use of blood, adverse transfusion events and overall patient outcomes; organize for the NBTS/blood centers receive at least one quality control assessment in the year.
6. Monitoring and Evaluation: assist the NBTS and blood centers have a written M&E plan; support the development of recommendations and guidance on systems for collecting, managing, and analyzing data on key programmatic indicators.
